| Michel, Bruno |
n. a. |
IBM (Group) |
Switzerland |
| Michel, Jan (3B Pharmaceuticals 201602 Director Finance + Corp Development) |
Chief Financial Officer (CFO) |
3B Pharmaceuticals GmbH (3BP) |
Germany |
| Michel, Martin (Inkef Capital 201710 Senior Advisor) |
Consultant (economic/technology) |
ABP (Stichting Pensioenfonds) (Group) |
Netherlands |
| Michel, Willy (Finox AG 201310 majority shareholder + Board President) |
Board member, non-executive |
Finox AG (Finox Biotech) |
Switzerland |
| Michelmore, Sara (MacDougall 202003) |
Public Relations Manager / Investor Relations Manager |
MacDougall Advisors Inc. |
United States (USA) |
| Michels, Nicola (New Jersey (govt) 201905 Managing Director of Europe office of Choose New Jersey) |
Managing Director |
New Jersey (govt region) |
Germany |
| Micki, Tania (Tecan 202003– CFO before Sulzer AG + Monsanto + Gate Group + General Mills) |
Chief Financial Officer (CFO) |
Tecan (Group) |
Switzerland |
| Middendorp, Oliver (Numab 201703 CBO + Co-Founder before Esbatech 2004–2010) |
Chief Business Officer (CBO) |
Numab (Group) |
Switzerland |
| Middleman, Matt (LifeSci Public Relations 201712 Founding Partner before Russo Partners LLC 201512) |
Public Relations Manager / Investor Relations Manager |
LifeSci (Group) |
United States (USA) |
| Mielach, Andrew (LifeSci 201404 at LifeSci Communications before Tiberend Strategic Advisors) |
Public Relations Manager / Investor Relations Manager |
Tiberend Strategic Advisors (NY) |
United States (USA) |
| Mielke, Orell (KeyNeurotek 200607– VP Clinical RnD before Parexel International) |
Research & Development Manager |
KeyNeurotek (Group) |
Germany |
| Miels, Luke (GSK 201701– President Global Pharma before AstraZeneca + Roche + Sanofi-Aventis) |
President/Director/Head Business Group/Unit/Division |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
| Miersch, Helfried (AMETEK 201003 SPECTRO Analytical Technischer Vertrieb ICP/XRF) |
n. a. |
AMETEK (Group) |
Germany |
| Mietzsch, Andreas (Biocom 201007 CEO) |
Chief Executive Officer (CEO) |
Biocom (Group) |
Germany |
| Miille, Mike (Bayer 201410 Head of Business Management Biologics at Bayer CropScience before AgraQuest) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Mikitani, Hiroshi (Mickey) (Raktuen CEO + Founder) |
Chief Executive Officer (CEO) |
Rakuten (Group) |
Japan |
| Milad, John E. (Quanta Fluid Solutions Ltd 201411 CEO) |
Chief Executive Officer (CEO) |
Quanta Fluid Solutions Ltd. |
United Kingdom (GB) |
| Milde, Heiko (Hamburg (govt) 201208 Managing Director of Innovationsstarter Hamburg GmbH) |
Managing Director |
Hamburg (govt region) |
Germany |
| Miles, Brad (BMC Communications 201803) |
Public Relations Manager / Investor Relations Manager |
PNC Financial Services (Group) |
United States (USA) |
| Miles, Nick (Cabinet Privé de Conseils 202009) |
Public Relations Manager / Investor Relations Manager |
Cabinet Privé de Conseils S.A. |
Switzerland |
| Miles, Nick (Speedel 200301–200802 Director Communications) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Switzerland |
| Miller, Dwayne (Max Planck 201211– Founding Director of MPI for Structure and Dynamics of Matter) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
Germany |
| Miller, Kelly (Thermo Fisher 201806 VP/General Manager Laboratory Analytical Reagents) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
| Miller, Ken (Thermo Fisher 201111– VP Marketing Life Sciences MS before Agilent Marketing Director LC/MS) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Miller, Rik (DuPont 201410 President DuPont Crop Protection) |
President/Director/Head Business Group/Unit/Division |
DuPont (Group) |
United States (USA) |
| Miller, Thomas (Siemens Healthcare Workflow 200801 CEO) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Miller, Tom (GreyBird Ventures 201908 Partner + 201908– Board Chairman at GNA Biosolutions) |
Partner (venture partner) |
GreyBird Ventures |
|
| Miller, Walter (Mologen 201604– CFO before Nuvisan Gmbh + Santhera Pharmaceuticals) |
Chief Financial Officer (CFO) |
Mologen (Group) |
Germany |
| Millman, Robert (Vesigen Therapeutics 202007 CEO + Co-Founder before Alnylam 200606 Chief IP Councel) |
Chief Executive Officer (CEO) |
Alnylam (Group) |
United States (USA) |
| Mills, Adrian (Novimmune 201409– CBO before GSK since 2000) |
Chief Business Officer (CBO) |
Novimmune S.A. |
Switzerland |
| Mills, Clare (Univ Manchester 201303 Prof at Allergy + Respiratory Centre) |
Professor |
University of Manchester (UoM) |
United Kingdom (GB) |
| Mills, Roger G. (Addex 201611– CMO before Acadia Pharmaceuticals + Pfizer + Gilead + Abbott + Wellcome) |
Chief Medical Officer (CMO) |
Addex (Group) |
Switzerland |
| Milner, Tom (Ametek 201009 SPECTRO) |
Public Relations Manager / Investor Relations Manager |
AMETEK (Group) |
Germany |
| Milosevich, Greg (Danaher 202011 President of Beckman Coulter Life Sciences) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Miltenyi, Stefan (Miltenyi Biotec 201404 Founder + President) |
President/Director/Head Business Group/Unit/Division |
Miltenyi Biotec (Group) |
Germany |
| Minami, Hiroko (ICN 200810– President) |
n. a. |
International Council of Nurses (ICN) |
Switzerland |
| Minkova, Miroslava (Bruker Corp 201611 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
United States (USA) |
| Minotta, Mauricio (Thermo Fisher 201511) |
public relations / investor relations |
Thermo Fisher (Group) |
United States (USA) |
| Mintun, Mark (Lilly 201812 VP Neurodegeration + Pain Research) |
Research & Development Manager |
Eli Lilly (Group) |
United States (USA) |
| Miralles, Diego (Flagship Pioneering 202102– CEO-Partner + CEO of Laronde before Vividion Tx +Adaptive Tx + JnJ) |
Chief Executive Officer (CEO) |
Laronde (US) |
United States (USA) |
| Mirovsky, Pavel (PharmaSwiss 201102 CEO) |
Chief Executive Officer (CEO) |
Valeant (Group) |
Switzerland |
| Mischau, Reinhold (Peqlab Biotechnologie GmbH 200710 Managing Director) |
Managing Director |
Avantor (Group) |
Germany |
| Miserez, André (Diagene 201104 CEO) |
Chief Executive Officer (CEO) |
Diagene (Group) |
Switzerland |
| Mistry, Jehangir (Merck (DE) 201201 Director RnD at EMD Millipore) |
Research & Development Manager |
Merck (DE) (Group) |
United States (USA) |
| Mita, Masayuki (Takasago 201412 SVP Fragrance + Aroma Chemical Division) |
President/Director/Head Business Group/Unit/Division |
Takasago International Corporation |
Japan |
| Mitan, Ania (SIRS-Lab 200812– Executive VP Commercial before Eli Lilly European Marketing Director) |
Sales Manager / Marketing Manager |
Endress+Hauser (Group) |
Germany |
| Mitchell, Rob (Roche 200904 Global Head Virology Business) |
Product Manager (personnel) |
Roche (Group) |
Switzerland |
| Mitterlehner, Reinhold (Austria (govt) 201210 Minister of Economy) |
Minister |
Austria (govt) |
Austria |
| Mittmann, Laura (Trophic Communications 202002) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Miura, Yasuo (Shimadzu 201304 Managing Director of Shimadzu Europa GmbH) |
Managing Director |
Shimadzu (Group) |
Germany |
| Mix, Guido (Bruker 200905 Bruker Daltonik Director Business Development MALDI Biotyper) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
Germany |
| Mixtacki, Heiko (Biostep GmbH 200709) |
n. a. |
Biostep GmbH |
Germany |
| Mizoue, Laura S. (201904 SomaLogic) |
Public Relations Manager / Investor Relations Manager |
SomaLogic Inc. |
United States (USA) |
| Mizrahi, Jacques (Aravis + INSERM + ElsaLys 201701 Consultant before Roche 200512 Head of Metabolic + Vascular Diseases) |
Venture Partner |
Aravis (Group) |
Switzerland |
| Mlodzianowski, Werner |
n. a. |
Bremerhaven University of Applied Sciences (Hochschule Bremerhaven) |
Germany |
| Moarefi, Ismail (Crelux 200502– co-founder) |
Company Founder |
WuXi PharmaTech (Group) |
Germany |
| Modersitzki, Jan (Univ Lübeck 201004 Professor) |
Professor |
University of Lübeck (Universität zu Lübeck, UzL) |
Germany |
| Modes, Ralf (Askion 201303 Managing Director) |
Managing Director |
Askion (Group) |
Germany |
| Modig, Berndt (Pharvaris CEO before Prosensa 201003 CFO before Jerini 200310– CFO before Surplex AG) |
Chief Executive Officer (CEO) |
Pharvaris B.V. |
Netherlands |
| Moebius, Ulrich (MorphoSys 200902– Head Pre-clinical develop before Medigene) |
Research & Development Manager |
MorphoSys (Group) |
Germany |
| Moedas, Carlos (EU (govt) 201710 Commissioner for Research, Science + Innovation) |
Minister |
EU (govt) |
Luxembourg |
| Moelker, Adriaan (BRAIN 202002– CEO before Flint Group + AB Enzymes + Genencor + DSM) |
Chief Executive Officer (CEO) |
BRAIN (Group) |
Germany |
| Moellgaard, Henrik (Direvo Industrial Biotech 200807– before Christian Hansen) |
n. a. |
Direvo Industrial Biotechnology (Group) |
Germany |
| Moesslang, Angelo (InGeneron 201710– CEO before CFO at Fresenius Medial Care North America) |
Chief Executive Officer (CEO) |
InGeneron (Group) |
Germany |
| Mohadjer, Aydin (CAMAG 201302 Corporate Marketing Manager) |
Sales Manager / Marketing Manager |
CAMAG (Group) |
Switzerland |
| Mohr, Bernhard (Evonik 201201– Head of Corporate Venturing) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
| Mohr, Deana (Muvon Therapeutics 202104 CEO + Co-Founder) |
Chief Medical Officer (CMO) |
Muvon Therapeutics AG |
|
| Mohr, Fabian (High-Tech Gründerfonds 201811) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Mohr, Heribert (Thermo Fisher 201304– Global Strategic BusDev Manager Chromatography + MS division) |
Business Development Manager / Strategy Manager |
Thermo Fisher (Group) |
Germany |
| Mohr, Lars (berlinbiotechpark 201104 Managing Director) |
Managing Director |
berlinbiotechpark GmbH & Co. KG |
Germany |
| Mohr, Mareike (MC Services 201207 Public Relations) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Mohr, Ulrich (Cultex Laboratories GmbH 201105 Managing Director + co-founder) |
Managing Director |
Cultex Laboratories GmbH |
Germany |
| Moingeon, Benjamin (GATC Biotech 201503 Sales Director) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Germany |
| Moldenbauer, Gerhard |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Moll, Fred (Ciruit Therapeutics 201312 Chairman) |
Board member |
Circuit Therapeutics Inc. |
United States (USA) |
| Moll, Gert (Lanthio Pharma 201410 CEO) |
Chief Executive Officer (CEO) |
MorphoSys (Group) |
Netherlands |
| Moll, Nathalie (EFPIA 201704– Director General before Secretary General at EuropaBio) |
President/Director/Head Business Group/Unit/Division |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Moll, Peter (Otsuka 201103 Managing Director of ABX GmbH) |
Managing Director |
Otsuka (Group) |
Germany |
| Momsen, Björn (High-Tech Gründerfonds 201010 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Monin, Jean-Fabien (AC Immune 200901– CFO before 14y at bioMérieux CFO Central Europe) |
Chief Financial Officer (CFO) |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Monko, Michael (Sequenom 200608– Senior VP Sales + Marketing before UpState Chemicon before Invitrogen Corp) |
n. a. |
LabCorp (Group) |
United States (USA) |
| Monroe, Thomas Lawrence (Tom) (Actelion 201604 CEO of Vaxxilon AG) |
Chief Executive Officer (CEO) |
Idorsia (Group) |
Switzerland |
| Montag, Bernd (Siemens 201802 CEO of Siemens Healthineers) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Montagner, Carlo (200801– CEO + Founder of STA before Alchemia + Abraxas Bioscience et al + Schering 200510) |
Chief Executive Officer (CEO) |
Specialised Therapeutics Australia Pty Ltd. (STA) |
Australia |
| Montana, John (Charles River 201709– VP Integr Drug Discovery/Strategic Projects joined 2014 before Argenta+Paradigm) |
Business Development Manager / Strategy Manager |
Charles River (Group) |
United States (USA) |
| Montanari, Bruno (Seroba Life Sciences 201905 before Omnes Capital 201607 Partner) |
Partner (venture partner) |
Seroba (Group) |
Ireland, Republic of |
| Montenbruck, Ingo (Ingenium 200606 Senior Director BusDev) |
Business Development Manager / Strategy Manager |
Vivoryon (Group) |
Germany |
| Monz, Ludwin (Carl Zeiss 201401 CEO of Carl Zeiss Medictec AG) |
Chief Executive Officer (CEO) |
Carl Zeiss (Group) |
Germany |
| Moonen, Kees (Kreatech 200909– CEO before Green Cross Vaccine CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Netherlands |
| Moore, Jeffrey R. (Helicos 201208 SVP + CFO) |
Chief Financial Officer (CFO) |
Helicos BioSciences Corporation (Nasdaq: HLCS) |
United States (USA) |
| Moore, Judith (AC Immune 202003 Global Head of Communications) |
Public Relations Manager / Investor Relations Manager |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Moore, Kevin (Tecan 201011 Director Market and Application Management for BioPharma) |
Product Manager (personnel) |
Tecan (Group) |
Switzerland |
| Mora, Luis (Zeltia 201208– Managing Director of newly founded Pharma Mar GmbH) |
Managing Director |
PharmaMar (Group) |
Germany |
| Moradian, Eddie (MD Biosiences 202010 CEO) |
Chief Executive Officer (CEO) |
MLM Medical Labs (Group) |
United States (USA) |
| Morand, Olivier (Azafaros 201807– CEO before Idorsia + Actelion + Roche) |
Chief Executive Officer (CEO) |
Azafaros B.V. |
Netherlands |
| Moreno, Gerardo Cabanas (IPN 201203 Director of CMMN) |
Researcher (university / research institute) |
Instituto Politécnico Nacional (IPN) (National Polytechnic Institute, MX) |
Mexico |
| Morgan, Jeremy (Eli Lilly 201204 Managing Director of Lilly Deutschland GmbH) |
Managing Director |
Eli Lilly (Group) |
Germany |
| Morgenthaler, Nils (Bruker 201504 VP Medical Affairs at Bruker Daltonics division) |
n. a. |
Bruker (Group) |
United States (USA) |
| Morich, Frank (Takeda 201008– EVP International Operations before Noxxon CEO before Innogenetics + AM-Pharma + Bayer) |
President/Director/Head Business Group/Unit/Division |
Takeda (Group) |
Japan |
| Morie, Brad (Biocrates 200805 VP Business Development LEFT before 10/11) |
Business Development Manager / Strategy Manager |
Biocrates (Group) |
Austria |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 43 44 45 ... 73 74 75 
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
